pH-sensitive liposomal cisplatin improves peritoneal carcinomatosis treatment without side-effects

Posted by & filed under Health Sciences.

Scientists have developed and characterized a circulating and pH-sensitive liposome containing cisplatin (SpHL-CDDP) aiming to promote the release of cisplatin near the tumor as well as decreasing toxicity. The development of analog drugs and new formulations are current strategies for increasing the effectiveness and safety of cisplatin as an anti-peritoneal carcinomatosis drug.

Comments are closed.

Feedback

eSTEM Feedback

We appreciate any and all feedback about our site; praise, ideas, bug reports you name it!

e.g. Indifferent, Undecided, Unconcerned e.g.Kidding, Amused, Silly e.g. Happy, Confident, Grateful e.g. Sad, Dissapointed, Confused, Angry